Literature DB >> 34373674

What Are the Risk Factors for an Upper Extremity Deep Venous Thrombosis After Orthopaedic Irrigation and Debridement and Peripherally Inserted Central Catheter Placement?

Mark J Lambrechts1, Bradley S Spence2, Shelby M Harris3, Andrea Gilmore3, Jasraj Marjara3, Zhengye Si2, Blaine T Manning4, James L Cook4, Emily V Leary4, Matthew J Smith2.   

Abstract

BACKGROUND: Peripherally inserted central catheter (PICC) placement is necessary for delivery of intravenous (IV) antibiotics to treat bone and soft tissue infections. Upper extremity deep venous thrombosis (DVT) after PICC placement is a complication with unknown incidence in the orthopaedic literature. The major objectives of this study are Identifying the rate of upper extremity PICC-associated DVTs after orthopaedic procedures;Which orthopaedic subspecialties are most likely to encounter an upper extremity PICC-associated DVT?What surgeries or medical comorbidities are risk factors for upper extremity PICC-associated DVTs?Does type of DVT chemoprophylaxis decrease the risk of an upper extremity PICC-associated DVT?
METHODS: A retrospective review of electronic medical records (EMR) was performed to include all patients undergoing irrigation and debridement (I&D) for treatment of orthopaedic surgery-related infections over a 10-year period. All patients with PICC placement were included for analyses. Age, sex, and medical comorbidities were extracted from the EMR. Mann-Whitney non-parametric tests, Fisher's exact tests, Chi-square tests, and Cochran-Mantel-Haenszel (CMH) tests were used to determine associations with DVT events for those with PICCs based on medical comorbidities, PICC lumen size, team placing the PICC, impact of implant removal, and protective effect of DVT chemoprophylaxis. Significance was set at p<0.05.
RESULTS: Twenty-one of 660 patients (3.18% rate) were found to have an upper extremity PICC-associated DVT. A history of DVT (OR=8.99 [95% CI: 3.39, 49.42]) was significantly associated with an upper extremity PICC-associated DVT. The greatest risk for an upper extremity PICC-associated DVT was intramedullary implant removal (OR=12.43 [95% CI: 3.13, 49.52]). The type of DVT chemoprophylaxis did not significantly affect the likelihood of an upper extremity PICC-associated DVT.
CONCLUSION: Intramedullary implant removal and a history of DVT are risk factors for an upper extremity PICC-associated DVT. The results of this study should be of particular interest to surgeons who do not typically give DVT prophylaxis and plan to perform surgery on patients with CHF, a history of a DVT, or plan to manipulate the intramedullary canal. Copyright 2021 by the Missouri State Medical Association.

Entities:  

Mesh:

Year:  2021        PMID: 34373674      PMCID: PMC8343646     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  13 in total

1.  All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries.

Authors:  Patrick Lefebvre; François Laliberté; Edith A Nutescu; Mei Sheng Duh; Joyce LaMori; Brahim K Bookhart; William H Olson; Katherine Dea; Jeff Schein; Scott Kaatz
Journal:  J Manag Care Pharm       Date:  2012-06

2.  Risk of symptomatic DVT associated with peripherally inserted central catheters.

Authors:  R Scott Evans; Jamie H Sharp; Lorraine H Linford; James F Lloyd; Jacob S Tripp; Jason P Jones; Scott C Woller; Scott M Stevens; C Gregory Elliott; Lindell K Weaver
Journal:  Chest       Date:  2010-10       Impact factor: 9.410

3.  Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations.

Authors:  Alex C Spyropoulos; Jay Lin
Journal:  J Manag Care Pharm       Date:  2007 Jul-Aug

4.  Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies.

Authors:  W Saber; T Moua; E C Williams; M Verso; G Agnelli; S Couban; A Young; M De Cicco; R Biffi; C J van Rooden; M V Huisman; D Fagnani; C Cimminiello; M Moia; M Magagnoli; S P Povoski; S F Malak; A Y Lee
Journal:  J Thromb Haemost       Date:  2011-02       Impact factor: 5.824

5.  Peripherally inserted central catheter-related deep vein thrombosis: contemporary patterns and predictors.

Authors:  V Chopra; D Ratz; L Kuhn; T Lopus; A Lee; S Krein
Journal:  J Thromb Haemost       Date:  2014-06       Impact factor: 5.824

6.  Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome.

Authors:  David A MacDougall; Anthony L Feliu; Stephen J Boccuzzi; Jay Lin
Journal:  Am J Health Syst Pharm       Date:  2006-10-15       Impact factor: 2.637

Review 7.  Peripherally Inserted Central Catheter-associated Deep Vein Thrombosis: A Narrative Review.

Authors:  Nabil Fallouh; Helen M McGuirk; Scott A Flanders; Vineet Chopra
Journal:  Am J Med       Date:  2015-02-16       Impact factor: 4.965

8.  Venous thromboembolism in heart failure: preventable deaths during and after hospitalization.

Authors:  Gregory Piazza; Samuel Z Goldhaber; Darleen M Lessard; Robert J Goldberg; Catherine Emery; Frederick A Spencer
Journal:  Am J Med       Date:  2011-03       Impact factor: 4.965

9.  Risk of venous thromboembolism in hospitalized patients with peripherally inserted central catheters.

Authors:  Bob L Lobo; Georgeta Vaidean; Joyce Broyles; Anne B Reaves; Ronald I Shorr
Journal:  J Hosp Med       Date:  2009-09       Impact factor: 2.960

Review 10.  Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis.

Authors:  Vineet Chopra; Sarah Anand; Andy Hickner; Michael Buist; Mary Am Rogers; Sanjay Saint; Scott A Flanders
Journal:  Lancet       Date:  2013-05-20       Impact factor: 79.321

View more
  1 in total

1.  The incidence and risk of venous thromboembolism associated with peripherally inserted central venous catheters in hospitalized patients: A systematic review and meta-analysis.

Authors:  Anju Puri; Haiyun Dai; Mohan Giri; Chengfei Wu; Huanhuan Huang; Qinghua Zhao
Journal:  Front Cardiovasc Med       Date:  2022-07-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.